Veda Giri, MD, on innovative approaches to genetic testing in prostate cancer
In a recent interview with Urology Times®, Veda N. Giri, MD, outlined alternative care models that could help…
Veda Giri, MD, on barriers to genetic testing in prostate cancer
In a recent interview with Urology Times®, Veda N. Giri, MD, outlined some of the key barriers to…
Enrollment goal met in trial of individualized ADT/RT for high-risk prostate cancer
The target enrollment has been met in the phase 3 PREDICT-RT (NRG-GU009; NCT04513717) trial, evaluating a risk stratification…
Key takeaways from the COMRADE trial in CRPC, with Rana McKay, MD
Findings from the phase 2 COMRADE trial (NCT03317392)were recently shared at the 2025 American Society of Clinical Oncology Annual…
Referral rates for genetic counseling in renal cell carcinoma remain low
Although national guidelines recommend genetic counseling for all patients with early-onset or bilateral renal cell carcinoma (RCC), the…
Hong Truong, MD, on genetic counseling for patients with kidney cancer
Although current guidelines recommend genetic counseling for all patients with early-onset or bilateral renal cell carcinoma (RCC), only…
Ongoing clinical trials and emerging agents in BCG-unresponsive NMIBC
Novel agents are rapidly transforming the treatment landscape for BGC-unresponsive non–muscle invasive bladder cancer (NMIBC). This new wave…
Tool predicts prostate cancer outcomes using patient-reported data
In this interview, Bashir Al Hussein Al Awamlh, MD, MPH, a urologic oncologist and assistant professor of urology…